Epidemiology and Ecology of Cholera in Africa
- Institution
- Johns Hopkins University, MD
- Principal investigator
- David A Sack
- Funding
- $726K
- Duration
- 2017–2028
Moonbase score
Still being scored
Abstract
The long-term goal is the elimination of cholera in Africa by identifying patterns of transmission that will enable endemic African countries reduce the number of districts with cholera by stopping transmission within and between districts. This goal is consistent with the goal of the Global Task Force for Cholera Control to “eliminate” cholera from > 20 countries by 2030. Using innovative surveillance, molecular and GIS methods, the study will conduct detailed molecular epidemiological studies in Nigeria, and Uganda to detect the spread of specific V. cholerae (Vc) genetic lineages and vibriophage and will monitor the impact of interventions intended to prevent cholera’s spread. By stopping cholera’s transmission within a country, the country will reduce the number of districts with cholera; thereby, creating a “cholera elimination scorecard” with which to monitor progress toward national elimination. This application builds on evidence from our initial RO1 study of cholera in Africa showing that cholera lineages “spread to” rather than “emerge from” endemic areas, and strategies to control cholera need to adapt to this new understanding. Many Sub-Saharan African countries are “endemic” since they regularly report cholera cases; however, most outbreaks are short (few weeks), are limited to a few districts or subdistricts and are caused by genetic lineages that move through an area and then die out. Because water, sanitation and hygiene (WASH) is poor, these areas remain susceptible when a new genetic lineage is introduced. To improve the effectiveness of an elimination strategy, improved surveillance is needed to detect outbreaks quickly to intervene and prevent outward transmission. Rapid molecular surveillance is now possible with rapid diagnostic tests (RDTs) able to immediately identify cases while also providing DNA samples for PCR confirmation and molecular characterization using MLVA. Stools will also be cultured to create a repository of Vc strains, and feces will be spotted on filter paper and dried. The dried fecal samples (DFS) can be stored indefinitely without refrigeration, are easily transported, are not biohazardous, and can be used to detect Vc and vibriophage. Sewage samples will be collected to detect Vc and phage during and between outbreaks to further characterize transmission of genetic lineages and phage. By combining intensive surveillance, molecular epidemiology, and rapid evaluation of case GIS coordinates, quickly identified patterns of cholera transmission should improve targeted interventions (vaccine and WASH). The project uses innovative new technologies developed during the initial RO1 grant applicable to conditions in developing countries. These include evaluation of RDTs that allow results from RDTs to declare an outbreak as well as be used for molecular studies, rapid detection of Vc using a new simplified LAMP assay (termed RLDT), genotyping (MLVA) from DFS and RDTs, d) whole genome sequencing (WGS) from isolates as well as DFS, and d) phage detection from DFS.
Research team
- Amanda Kay DebesPI
- David A SackPI
LOADING MOONBASE SCORE
Questions for Johns Hopkins University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Johns Hopkins University36
A cross protective multivalent vaccine for Shigella and ETEC
David A Sack · $720K · 2023–2028
- NIH · Johns Hopkins University72
Development, Piloting and Dissemination of an Integrated Clinical and Social Multi-level Decision Support Platform to Address Social Determinants of Health Among Minority Populations in Baltimore City
Elham Hatef-Naimi · $611K · 2021–2025
- NIH · Johns Hopkins University66
Glucose instability and neurocognitive outcomes in older adults
Elizabeth Selvin · $697K · 2021–2027